To determine whether joint CETP and SGLT2 inhibition has an impact on diabetes risk within each of our groups, we leverage the same analytical framework as detailed above for glycated hemoglobin but use logistic regression instead of linear regression because diabetes is a binary phenotype. This evidence concerns the gene SLC5A2 and diabetes mellitus.